Literature DB >> 16488355

Survival estimates of a prognostic classification depended more on year of treatment than on imputation of missing values.

Merel R van Dijk1, Ewout W Steyerberg, Sally P Stenning, J Dik F Habbema.   

Abstract

BACKGROUND AND
OBJECTIVE: The International Germ Cell Consensus (IGCC) classification defines good, intermediate, and poor prognosis groups among patients with nonseminomatous germ cell cancer. In the database used to develop the IGCC classification (n = 5,202), >40% of patients were excluded because of missing values (n = 2,154). We looked for effects of this exclusion on survival estimates in the three IGCC prognosis groups. STUDY DESIGN AND
SETTING: We imputed missing values using a multiple imputation procedure. The IGCC classification was applied to patients with complete data (n = 3,048) and with imputed data (n = 2,154), and 5-year survival was calculated for each prognosis group.
RESULTS: Patients with missing values had a lower 5-year survival than those without missing values: 76% vs. 82%. Five-year survival in the complete and imputed data samples was 92% and 87% for the good prognosis groups and 80% and 70% for the intermediate prognosis groups, whereas 5-year survival for the poor prognosis groups in both samples was similar (50% and 47%, respectively). This difference in survival was largely explained by a higher proportion of missing values among patients treated before 1985, who had a worse survival than patients treated after 1985.
CONCLUSION: Multiple imputation of the missing values led to lower survival estimates across the IGCC prognosis groups, compared with estimates based on the complete data. Although imputation of missing values gives statistically better survival estimates, adjustments for year of treatment are necessary to make the estimates applicable to currently diagnosed patients with testicular cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16488355     DOI: 10.1016/j.jclinepi.2005.08.015

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  4 in total

1.  Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting.

Authors:  Saskia A M van de Schans; Maryska L G Janssen-Heijnen; Marten R Nijziel; Ewout W Steyerberg; Dick Johan van Spronsen
Journal:  Haematologica       Date:  2010-05-21       Impact factor: 9.941

2.  Imputation of missing values of tumour stage in population-based cancer registration.

Authors:  Nora Eisemann; Annika Waldmann; Alexander Katalinic
Journal:  BMC Med Res Methodol       Date:  2011-09-19       Impact factor: 4.615

3.  Clinical Characteristics and Treatment Outcomes of Patients With Advanced Germ Cell Tumor Treated at a Tertiary Cancer Center in Brazil.

Authors:  Vitor Florin Vasconcellos; Diogo Assed Bastos; Allan A Lima Pereira; Gabriel Yoshiyuki Watarai; Bruno Rodriguez Pereira; Adriana de Godoy; Jamile Almeida-Silva; David Queiroz Borges Muniz; Giuliano Betoni Guglielmetti; William Carlos Nahas; Carlos Dzik
Journal:  J Glob Oncol       Date:  2019-02

4.  A decision-analytic approach to define poor prognosis patients: a case study for non-seminomatous germ cell cancer patients.

Authors:  Merel R van Dijk; Ewout W Steyerberg; J Dik F Habbema
Journal:  BMC Med Inform Decis Mak       Date:  2008-01-03       Impact factor: 2.796

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.